By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

REGENX Biosciences, LLC 

750 17th St. NW, Suite 1100

Washington  D.C.   20006  U.S.A.
Phone: 202-785-7438 Fax:


SEARCH JOBS








Company News
REGENX Biosciences, LLC: Attacking A Rare Disease At Its Source With Gene Therapy 8/27/2014 6:48:27 AM
REGENX Biosciences, LLC And Voyager Pharmaceutical Corporation Announce License Agreement 6/2/2014 10:03:33 AM
REGENX Biosciences, LLC Enters Into License Agreement With AAVLife For Development Of Treatments For Friedreich's Ataxia Using NAV(R) Vectors 4/29/2014 11:15:18 AM
REGENX Biosciences, LLC And AveXis Enter Into Exclusive License Agreement For The Development Of Treatments For Spinal Muscular Atrophy Using NAV® rAAV9 Vectors 4/1/2014 11:09:56 AM
REGENX Biosciences, LLC And Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Enter Into License Agreement For Development Of Treatments For Serious, Rare Lysosomal Storage Disorder Using NAV® rAAV9 Vectors 3/10/2014 10:12:48 AM
Dr. James Brown, COO, REGENX Biosciences, LLC, Elected To SAFE-BioPharma, LLC Board Of Directors 2/11/2014 10:08:08 AM
REGENX Biosciences, LLC And LYSOGENE Enter Into Exclusive License Agreement For Development Of Treatments For Serious, Rare Lysosomal Storage Disorder Using NAV(R) rAAVrh10 Vectors 12/5/2013 9:45:32 AM
Fidelity Biosciences and REGENX Biosciences, LLC Form New Company Dimension Therapeutics 10/31/2013 12:19:59 PM
REGENX Biosciences, LLC and Audentes Therapeutics Enter into Exclusive License Agreement for Development of Treatments for Serious, Rare Muscle Diseases Using NAVTM Vectors 7/30/2013 10:06:57 AM
REGENX Biosciences, LLC and Audentes Therapeutics Enter Into Exclusive License Agreement for Development of Treatments for Serious, Rare Muscle Diseases Using NAV™ Vectors 7/30/2013 9:10:51 AM
12
//-->